
Gino Colan
Examiner (ID: 13822)
| Most Active Art Unit | 2921 |
| Art Unit(s) | 2921, 2925, 2973 |
| Total Applications | 1669 |
| Issued Applications | 1647 |
| Pending Applications | 9 |
| Abandoned Applications | 17 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19018992
[patent_doc_number] => 20240075163
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-07
[patent_title] => NOVEL LIPIDS AND LIPID NANOPARTICLE FORMULATIONS FOR DELIVERY OF NUCLEIC ACIDS
[patent_app_type] => utility
[patent_app_number] => 18/493428
[patent_app_country] => US
[patent_app_date] => 2023-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20399
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18493428
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/493428 | NOVEL LIPIDS AND LIPID NANOPARTICLE FORMULATIONS FOR DELIVERY OF NUCLEIC ACIDS | Oct 23, 2023 | Pending |
Array
(
[id] => 19402026
[patent_doc_number] => 20240285537
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-29
[patent_title] => COMPOSITIONS COMPRISING PGI2-RECEPTOR AGONISTS AND PROCESSES FOR THE PREPARATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/491529
[patent_app_country] => US
[patent_app_date] => 2023-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54395
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18491529
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/491529 | COMPOSITIONS COMPRISING PGI2-RECEPTOR AGONISTS AND PROCESSES FOR THE PREPARATION THEREOF | Oct 19, 2023 | Pending |
Array
(
[id] => 20633440
[patent_doc_number] => 12594304
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-04-07
[patent_title] => Method for treating liver cirrhosis by using composition comprising mesenchymal stem cell. extracellular vesicle produced by mesenchymal stem cell, and growth factor
[patent_app_type] => utility
[patent_app_number] => 18/376545
[patent_app_country] => US
[patent_app_date] => 2023-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4508
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18376545
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/376545 | Method for treating liver cirrhosis by using composition comprising mesenchymal stem cell. extracellular vesicle produced by mesenchymal stem cell, and growth factor | Oct 3, 2023 | Issued |
Array
(
[id] => 19081804
[patent_doc_number] => 20240108605
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-04
[patent_title] => MAZINDOL COMBINATION IN THE TREATMENT OF ATTENTION-DEFICIT/HYPERACTIVITY
[patent_app_type] => utility
[patent_app_number] => 18/480331
[patent_app_country] => US
[patent_app_date] => 2023-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3719
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18480331
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/480331 | MAZINDOL COMBINATION IN THE TREATMENT OF ATTENTION-DEFICIT/HYPERACTIVITY | Oct 2, 2023 | Abandoned |
Array
(
[id] => 18860058
[patent_doc_number] => 20230414492
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => INTRANASAL DELIVERY OF CANNABIDIOL TO TREAT CENTRAL NERVOUS SYSTEM DISORDERS
[patent_app_type] => utility
[patent_app_number] => 18/244391
[patent_app_country] => US
[patent_app_date] => 2023-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2896
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18244391
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/244391 | INTRANASAL DELIVERY OF CANNABIDIOL TO TREAT CENTRAL NERVOUS SYSTEM DISORDERS | Sep 10, 2023 | Abandoned |
Array
(
[id] => 18860408
[patent_doc_number] => 20230414842
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => METHOD FOR REDUCING TRANSMISSION OF DISEASES
[patent_app_type] => utility
[patent_app_number] => 18/463338
[patent_app_country] => US
[patent_app_date] => 2023-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9309
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18463338
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/463338 | METHOD FOR REDUCING TRANSMISSION OF DISEASES | Sep 7, 2023 | Pending |
Array
(
[id] => 19777465
[patent_doc_number] => 12226486
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-18
[patent_title] => Method for bowel preparation
[patent_app_type] => utility
[patent_app_number] => 18/455930
[patent_app_country] => US
[patent_app_date] => 2023-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11260
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18455930
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/455930 | Method for bowel preparation | Aug 24, 2023 | Issued |
Array
(
[id] => 18921528
[patent_doc_number] => 20240024532
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-25
[patent_title] => NOVEL MICROSPHERES USING ANIONIC POLYMER, PREPARATION METHOD AND COMPOSITION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/362164
[patent_app_country] => US
[patent_app_date] => 2023-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10959
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18362164
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/362164 | NOVEL MICROSPHERES USING ANIONIC POLYMER, PREPARATION METHOD AND COMPOSITION THEREOF | Jul 30, 2023 | Pending |
Array
(
[id] => 19263486
[patent_doc_number] => 20240207183
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-27
[patent_title] => SYSTEMS AND METHODS FOR PREPARING AND TRANSPORTING AN INJECTABLE SLURRY
[patent_app_type] => utility
[patent_app_number] => 18/358795
[patent_app_country] => US
[patent_app_date] => 2023-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7741
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 194
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18358795
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/358795 | SYSTEMS AND METHODS FOR PREPARING AND TRANSPORTING AN INJECTABLE SLURRY | Jul 24, 2023 | Abandoned |
Array
(
[id] => 18953441
[patent_doc_number] => 20240041768
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => MULTIFUNCTIONAL pO2/pH-SENSITIVE THERANOSTIC LIPOSOME NANOCARRIERS AND METHODS OF USING SAME
[patent_app_type] => utility
[patent_app_number] => 18/357810
[patent_app_country] => US
[patent_app_date] => 2023-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26152
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 1078
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18357810
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/357810 | MULTIFUNCTIONAL pO2/pH-SENSITIVE THERANOSTIC LIPOSOME NANOCARRIERS AND METHODS OF USING SAME | Jul 23, 2023 | Pending |
Array
(
[id] => 19049335
[patent_doc_number] => 20240091304
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => FORMULATIONS COMPRISING CYCLOSPORIN A
[patent_app_type] => utility
[patent_app_number] => 18/225475
[patent_app_country] => US
[patent_app_date] => 2023-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60319
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18225475
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/225475 | FORMULATIONS COMPRISING CYCLOSPORIN A | Jul 23, 2023 | Abandoned |
Array
(
[id] => 18921354
[patent_doc_number] => 20240024358
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-25
[patent_title] => THERAPEUTIC CLAY COMPOSITIONS AND METHODS OF USING
[patent_app_type] => utility
[patent_app_number] => 18/223252
[patent_app_country] => US
[patent_app_date] => 2023-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22445
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18223252
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/223252 | Therapeutic clay compositions and methods of using | Jul 17, 2023 | Issued |
Array
(
[id] => 18900674
[patent_doc_number] => 20240016159
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => AGRICULTURAL COMPOSITIONS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 18/352676
[patent_app_country] => US
[patent_app_date] => 2023-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10011
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18352676
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/352676 | AGRICULTURAL COMPOSITIONS AND METHODS | Jul 13, 2023 | Pending |
Array
(
[id] => 20200404
[patent_doc_number] => 12403169
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-02
[patent_title] => Compositions and methods related to
[patent_app_type] => utility
[patent_app_number] => 18/345643
[patent_app_country] => US
[patent_app_date] => 2023-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 35
[patent_no_of_words] => 18131
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18345643
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/345643 | Compositions and methods related to | Jun 29, 2023 | Issued |
Array
(
[id] => 18859380
[patent_doc_number] => 20230413813
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => ANTIMICROBIAL COMPOSITION COMPRISING A POLYIMIDE
[patent_app_type] => utility
[patent_app_number] => 18/213920
[patent_app_country] => US
[patent_app_date] => 2023-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7444
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18213920
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/213920 | ANTIMICROBIAL COMPOSITION COMPRISING A POLYIMIDE | Jun 25, 2023 | Pending |
Array
(
[id] => 19297683
[patent_doc_number] => 20240226249
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2024-07-11
[patent_title] => CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS
[patent_app_type] => utility
[patent_app_number] => 18/338030
[patent_app_country] => US
[patent_app_date] => 2023-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10083
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18338030
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/338030 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS | Jun 19, 2023 | Abandoned |
Array
(
[id] => 19297683
[patent_doc_number] => 20240226249
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2024-07-11
[patent_title] => CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS
[patent_app_type] => utility
[patent_app_number] => 18/338030
[patent_app_country] => US
[patent_app_date] => 2023-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10083
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18338030
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/338030 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS | Jun 18, 2023 | Abandoned |
Array
(
[id] => 19111114
[patent_doc_number] => 20240122864
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-18
[patent_title] => PARTICLES ENCAPSULATING FUSION PROTEINS CONTAINING LINKED EPITOPES
[patent_app_type] => utility
[patent_app_number] => 18/333103
[patent_app_country] => US
[patent_app_date] => 2023-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26279
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18333103
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/333103 | PARTICLES ENCAPSULATING FUSION PROTEINS CONTAINING LINKED EPITOPES | Jun 11, 2023 | Pending |
Array
(
[id] => 18784861
[patent_doc_number] => 20230372537
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-23
[patent_title] => LIPID NANOPARTICLE FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 18/332487
[patent_app_country] => US
[patent_app_date] => 2023-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42628
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -88
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18332487
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/332487 | Lipid nanoparticle formulations | Jun 8, 2023 | Issued |
Array
(
[id] => 18655728
[patent_doc_number] => 20230301592
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-28
[patent_title] => WEARABLE PATCHES AND DEVICES
[patent_app_type] => utility
[patent_app_number] => 18/319752
[patent_app_country] => US
[patent_app_date] => 2023-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4803
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18319752
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/319752 | WEARABLE PATCHES AND DEVICES | May 17, 2023 | Pending |